Which SSRI? A Meta-Analysis of Pharmacotherapy Trials in Pediatric Obsessive-Compulsive Disorder
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors conducted a meta-analysis of published randomized, controlled medication trials in children and adolescents with obsessive-compulsive disorder (OCD) to assess evidence for differential efficacy based on type of drug, study design, and outcome measure. METHOD: A systematic literature search was performed for articles pertaining to the pharmacological treatment of pediatric and/or adolescent OCD. All baseline, posttreatment, and change scores with standard deviations reported in each study were included in the analyses. Effect sizes for dependent measures were expressed as standardized mean differences. The analysis included data on efficacy for four selective serotonin reuptake inhibitors (SSRIs) (paroxetine, fluoxetine, fluvoxamine, and sertraline) and clomipramine, four study designs, four dependent outcome measures, and two types of outcome scores (change and posttreatment scores). Multivariate regression was performed to assess the degree to which the effect sizes varied with the methodological features of each study. RESULTS: Twelve studies with a total of 1,044 participants met all inclusion criteria for the analysis. The pooled standardized mean difference for the results of all studies was 0.46 and showed a highly significant difference between drug and placebo treatment. Only one of the four outcome measures evaluated was not sensitive to change with treatment. A multivariate regression analysis of drug effect with other variables controlled showed that clomipramine was significantly superior to each of the SSRIs but that the SSRIs were comparably effective. CONCLUSIONS: Although highly significant, the overall effect sizes for medication were modest. Similarities and differences between the variables studied that emerged in the meta-analysis may have implications for both clinical care and future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a response rate analysis from a large pediatric paroxetine trial, the response rate for patients with a diagnosis of OCD only (75%) was significantly greater than patients with comorbid psychopathology, for example, ADHD (56%), tic disorder (53%), and ODD (39%).”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [137]
In the citing paper
“Some studies suggest that the presence of tics may yield a less robust response to SSRIs.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
SCAHILL, L., RIDDLE, M. A., McSWIGGIN-HARDIN, M., ORT, S. I., KING, R. A., GOODMAN, W. K., CICCHETTI, D., & LECKMAN, J. F. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00023 · Cited by 2,045 · cited 1×
“Outcome measures included the Children’s YaleBrown Obsessive Compulsive Scale (8), the NIMH Global OCD Scale (15), the Clinical Global Impression (CGI) of severity of illness (16), and the Leyton Obsessional Inventory—Child Version (17).”
MethodSwedo, S. E. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810040041007 · Cited by 825
March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., Cutler, N. R., Dominguez, R., Ferguson, J., Muller, B., et al. (1998) · JAMA · doi:10.1001/jama.280.20.1752 · Cited by 469
Self-citationClomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466
RIDDLE, M. A., REEVE, E. A., YARYURA-TOBIAS, J. A., YANG, H. M., CLAGHORN, J. L., GAFFNEY, G., GREIST, J. H., HOLLAND, D., MCCONVILLE, B. J., PIGOTT, T., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00017 · Cited by 402
Leonard, H. L. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810120030006 · Cited by 369
Statistical versus traditional procedures for summarizing research findings.
Cooper, H. M., & Rosenthal, R. (1980) · Psychological Bulletin · doi:10.1037//0033-2909.87.3.442 · Cited by 353
DEVEAUGH-GEISS, J., MOROZ, G., BIEDERMAN, J., CANTWELL, D., FONTAINE, R., GREIST, J. H., REICHLER, R., KATZ, R., & LANDAU, P. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00008 · Cited by 349
Self-citationRIDDLE, M. A., SCAHILL, L., KING, R. A., HARDIN, M. T., ANDERSON, G. M., ORT, S. I., SMITH, J. C., LECKMAN, J. F., & COHEN, D. J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00011 · Cited by 345
PETERSON, B. S., PINE, D. S., COHEN, P., & BROOK, J. S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00014 · Cited by 335
GELLER, D. A., HOOG, S. L., HEILIGENSTEIN, J. H., RICARDI, R. K., TAMURA, R., KLUSZYNSKI, S., JACOBSON, J. G., & FLUOXETINE PEDIATRIC OCD STUDY TEAM (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00011 · Cited by 320
Self-citationA Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. Efficacy
BIEDERMAN, J., BALDESSARINI, R. J., WRIGHT, V., KNEE, D., & HARMATZ, J. S. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00022 · Cited by 310
Self-citationEfficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
Piccinelli, M., Pini, S., Bellantuono, C., & Wilkinson, G. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.4.424 · Cited by 282
Imipramine in Prepubertal Major Depressive Disorders
Puig-Antich, J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800130093012 · Cited by 279
The Leyton Obsessional Inventory-Child Version
BERG, C. J., RAPOPORT, J. L., & FLAMENT, M. (1986) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60602-6 · Cited by 261
Leonard, H. L. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340054007 · Cited by 229
Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder
Ackerman, D. L., & Greenland, S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00012 · Cited by 202
Fluoxetine in Children and Adolescents With OCD: A Placebo-Controlled Trial
LIEBOWITZ, M. R., TURNER, S. M., PIACENTINI, J., BEIDEL, D. C., CLARVIT, S. R., DAVIES, S. O., GRAAE, F., JAFFER, M., LIN, S.-H., SALLEE, F. R., et al. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00014 · Cited by 188
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., Emslie, G., & Carpenter, D. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322126313 · Cited by 187
Self-citationMcDougle, C. J., Goodman, W. K., Leckman, J. F., Barr, L. C., Heninger, G. R., & Price, L. H. (1993) · PubMed · Cited by 186
Sudden Death in Children Treated with a Tricyclic Antidepressant
Biederman, J. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199105000-00023 · Cited by 148
Self-citationAssessment of Severity and Change in Obsessive Compulsive Disorder
Goodman, W. K., & Price, L. H. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30214-4 · Cited by 126
Puig-Antich, J., Perel, J. M., Lupatkin, W. L., Chambers, W. J., Shea, C., Tabrizi, M. A., & Stiller, R. L. (1979) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)62210-x · Cited by 123
Spencer, T. J., Biederman, J., Wilens, T. E., Steingard, R. J., & Geist, D. E. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199301000-00029 · Cited by 109
Self-citationThe Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder
McDougle, C. J., Goodman, W. K., Leckman, J. F., Barr, L. C., Heninger, G. R., & Price, L. H. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00008 · Cited by 109
Scahill, L. D., Riddle, M. A., KING, R. A., Hardin, M. T., Rasmusson, A. M., Makuch, R., & Leckman, J. F. (1997) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1997.7.75 · Cited by 87
Kurlan, R., Como, P. G., Deeley, C., McDermott, M., & McDermott, M. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199304000-00009 · Cited by 86
Psychopharmacology for Young Children: Clinical Needs and Research Opportunities
Vitiello, B. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.983 · Cited by 85
Spencer, T. J., Biederman, J., Kerman, K. L., Steingard, R. J., & Wilens, T. E. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199303000-00017 · Cited by 60
Self-citationMarch, J. S., Johnston, H. F., Jefferson, J. W., Kobak, K. A., & Greist, J. H. (1990) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1990.1.133 · Cited by 27
Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
Thase, M. E. (2002) · PubMed · Cited by 25
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“The guidelines include panic disorder, agoraphobia, specific phobia, social anxiety disorder (SAD), generalized anxiety disorder (GAD), as well as obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD).”
BackgroundInfluentialAbramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Connolly, S. D., & Bernstein, G. A. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246070.23695.06 · Cited by 548
Metadata
- Authors
- Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., & Faraone, S. V.
- Venue
- American Journal of Psychiatry
- Published
- 2003-11-01
- Volume
- 160
- Issue
- 11
- Pages
- 1919-1928
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2069390699
- Cited by
- 434
- References
- 33
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.